HOME >> MEDICINE >> NEWS
Newer lung cancer treatments extend survival longer than traditional regimens

Patients with advanced non-small cell lung cancer who are treated with regimens containing paclitaxel and carboplatin survive longer than patients treated with older cisplatin-based regimens or supportive care, a new study finds.

"While advanced lung cancer remains incurable, this study provides additional evidence that paclitaxel- and carboplatin-based regimens can prolong survival of patients with this disease," said John Hainsworth, MD, lead study author and Director of Clinical Research at the Sarah Cannon Cancer Center. "Survival beyond two years has been uncommon with previous treatments for advanced non-small cell lung cancer. With these newer regimens, two-year survival is similar to what we used to see at one year with the best supportive care or older regimens."

This study provides long-term follow-up on 321 patients with newly-diagnosed stage IIIB or IV non-small cell lung cancer who were treated in one of three sequential phase II trials between March 1995 and April 1998. All three trials were conducted in The Minnie Pearl Cancer Research Network, a community-based clinical trials group. Each trial included a different treatment regimen: paclitaxel and carboplatin; paclitaxel, carboplatin and gemcitabine; and paclitaxel, carboplatin, and vinorelbine. Data from these trials were compared retrospectively to previous studies on supportive care or traditional cisplatin-based regimens.

After an average follow-up of 58 months, actual one-, two-, and three-year survival rates were 40 percent, 19 percent, and 7 percent, respectively. The actuarial four-year survival rate for the entire group was four percent.

When compared retrospectively to older cisplatin-based regimens (not containing a taxane), these paclitaxel- and carboplatin-based treatments increase one-year survival from 25 to 30 percent, to 35 to 40 percent. These regimens also improve survival substantially when compared to the 16 percent one-year survival rate
'"/>

Contact: Stacia Momburg
momburgs@asco.org
703-299-1014
American Society of Clinical Oncology
27-Jun-2002


Page: 1 2

Related medicine news :

1. Newer formulation of heparin improves outcomes for suspected heart attack patients
2. Newer rheumatoid arthritis drugs: Harmful on the liver?
3. Newer vitamin D formulation appears to help dialysis patients live longer
4. Newer form of gold standard drug helps kidney transplant patients do better in long term
5. Physicians Slow To Adopt Newer Drugs For Atrial Fibrillation
6. Hormonal treatment improves survival in high-risk prostate cancer patients
7. International breast cancer prevention study launches in the United States and Canada
8. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
9. Cultural and social factors influence prostate cancer treatment
10. Primary care office strategies may increase colon cancer screening
11. Benefits of lung cancer screening with CT questioned

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/14/2019)... ... May 14, 2019 , ... Impact Advisors, a ... industry, announced today that John Stanley, Vice President, has been named one of ... for the Western U.S., has been recognized in the Excellence in Healthcare category. ...
(Date:5/14/2019)... ... 14, 2019 , ... A high number of HIV cases among the LGBTQ ... the Houston area and the southern United States. Specifically, the sub-groups at greater ... with men (MSM) and transgender people of color ages 13 to 34. In ...
(Date:5/14/2019)... ... May 14, 2019 , ... Relatient, Inc., a leader in ... Check-In solution , a new product launched to reduce patient wait times and ... Relatient’s Patient Engagement platform introducing earlier touch points on the patient journey ...
(Date:5/14/2019)... ... May 14, 2019 , ... Forty-two billion dollars ... and procedures, according to market analysis company Orbis Research. “Treatments certainly can help,” ... Advanced Dermatology PC , “but for our skin, there’s free super-potent anti-aging care ...
(Date:5/14/2019)... ... 2019 , ... Dr. Steven Shoshany has been treating patients experiencing both acute ... cold laser therapy device, becoming the first chiropractor in Manhattan to do so. Since ... FDA clearances for treating pain and injuries, into his downtown practice. He recently finished ...
Breaking Medicine News(10 mins):
(Date:5/16/2019)... NEW YORK (PRWEB) , ... May 16, 2019 ... ... digital health platform and portfolio company of Topspin Partners, today announced the acquisition ... in the diabetes, mental health, back pain, and pain management areas. This acquisition ...
(Date:5/16/2019)... ... May 16, 2019 , ... Luma Health https://www.lumahealth.io/ ... Patient Intake. This new solution helps providers deliver a top-notch patient experience by ... on their device of choice, days or weeks prior to their appointment. By ...
(Date:5/15/2019)... ... May 15, 2019 , ... Claudius ... network’s new Vice President of Information Technology. Over the last 15 years, Moore ... for healthcare systems, while also creating a high-quality, efficient experience for patients. , ...
Breaking Medicine Technology:
Cached News: